...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Quote from a January 19, 2021 review
12
BKC
Jan 20, 2021 03:36PM

"BETi apabetalone (RVX-208) not only improves the cardiovascular outcomes of patients with type 2 diabetes after acute coronary syndrome,162 but also decreases the risk of atherosclerotic plaque rupture and major adverse cardiac events" (bolding added)

I assume the information in bold is new information???

 

Koo

Share
New Message
Please login to post a reply